UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
Astellas Pharma’s strong pipeline and revenue growth support a positive outlook. See why ALPMF stock is a "Buy," driven by ...
The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated Approval of Drugs and Biologics,” is a game-changer for ...
But what if you could avoid getting COVID-19 altogether? That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific conference in San ...
A new combination pill has been given the green light by the National Institute for Health and Care Excellence (Nice) to ...
2don MSN
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
1d
News-Medical.Net on MSNAlready approved drug avapritinib shows promise in treating high-grade gliomasHigh-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, ...
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results